Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10745702
Compositions and methods for inhibiting expression of the LECT2 gene
granted -
US 10736975
Infusion administration of conjugated monoclonal antibodies
granted -
US 10730929
Serpin fusion polypeptides and methods of use thereof
granted -
US 10723785
Serpin fusion polypeptides and methods of use thereof
granted -
US 10717993
Methods and compositions for increased transgene expression
granted -
US 10709812
Biodegradable hydrogel for tissue expansion
granted -
US 10688056
Implantable medical devices for extended release of therapeutic agents
granted -
US 10689443
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted -
US 10688090
Vilazodone inclusion complexes, compositions and preparation thereof
granted -
US 10689719
Bifidobacterium longum
granted -
US 10683499
Compositions and methods for modulating TTR expression
granted -
US 10660918
Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell
granted -
US 10662440
Self-limiting viral vectors encoding nucleases
granted -
US 10662416
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome
granted -
US 10653169
Food thickening agent, method for producing food thickening agent
granted -
US 10653743
Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
granted -
US 10647754
Stabilized single human CD4 domains and fusion proteins
granted -
US 10632255
Drug infusion device
granted -
US 10624850
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
granted -
US 10619154
Nuclease-mediated regulation of gene expression
granted -
US 10619158
Modulation of huntingtin expression
granted -
US 10619160
Compositions and methods for inhibiting expression of RRM2 genes
granted -
US 10610497
Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
granted -
US 10603250
One-pack type dentinal tubule occlusion material
granted